Imaging African trypanosomes

Parasite Immunology

Volumn 35, Issue 9-10, 2013, Pages 283-294

  MacLean, L ^a,d   Myburgh, E ^b   Rodgers, J ^c   Price, H P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Animal model; Electron microscopy; in vivo imaging; RNA interference; Tools and techniques; Trypanosoma spp

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; EFLORNITHINE; GREEN FLUORESCENT PROTEIN; MELARSOPROL; NIFURTIMOX; VARIANT SURFACE GLYCOPROTEIN;

AFRICAN TRYPANOSOMIASIS; ARTICLE; BLOOD BRAIN BARRIER; CELL CYCLE; CONFOCAL MICROSCOPY; CYTOSKELETON; DISEASE COURSE; EPIFLUORESCENCE MICROSCOPY; EPIMASTIGOTE; HUMAN; IMAGING SYSTEM; IMMOBILIZATION; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE VIABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TRYPANOSOMA BRUCEI; TRYPOMASTIGOTE; WHITE MATTER;

ANIMAL MODEL; ELECTRON MICROSCOPY; IN VIVO IMAGING; RNA INTERFERENCE; TOOLS AND TECHNIQUES; TRYPANOSOMA SPP;

ANIMALS; CELL SURVIVAL; HOST-PARASITE INTERACTIONS; HUMANS; MICROSCOPY, CONFOCAL; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84883524315     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12046     Document Type: Article

References (83)

1. Blum J, Schmid C & Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 2006; 97: 55-64.
2. Kennedy PGE. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004; 113: 496-504.
3. Simarro PP, Cecchi G, Franco JR, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis 2012; 6: e1859.
4. WHO. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases. In Crompton DWT (ed). Second WHO Report on Neglected Tropical Diseases. WHO/HTM/NTD/2013.1. 2013. WHO, 2012.
5. Simarro PP, Cecchi G, Paone M, et al. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 2010; 9: 57.
6. Hasker E, Lutumba P, Chappuis F, et al. Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency? PLoS Negl Trop Dis 2012; 6: e1950.
7. Kuepfer I, Schmid C, Allan M, et al. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. PLoS Negl Trop Dis 2012; 6: e1695.
8. Alirol E, Schrumpf D, Amici Heradi J, et al. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: medecins sans frontieres experience in the democratic republic of the congo. Clin Infect Dis 2013; 56: 195-203.
9. Simarro PP, Franco J, Diarra A, Postigo JA & Jannin J. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 2012; 139: 842-846.
10. Kennedy PG. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 2013; 12: 186-194.
11. Vaughan S & Gull K. The structural mechanics of cell division in Trypanosoma brucei. Biochem Soc Trans 2008; 36: 421-424.
12. Engstler M, Pfohl T, Herminghaus S, et al. Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 2007; 131: 505-515.
13. Broadhead R, Dawe HR, Farr H, et al. Flagellar motility is required for the viability of the bloodstream trypanosome. Nature 2006; 440: 224-227.
14. He CY, Ho HH, Malsam J, et al. Golgi duplication in Trypanosoma brucei. J Cell Biol 2004; 165: 313-321.
15. Tyler KM, Fridberg A, Toriello KM, et al. Flagellar membrane localization via association with lipid rafts. J Cell Sci 2009; 122: 859-866.
16. Hill KL. Parasites in motion: flagellum-driven cell motility in African trypanosomes. Curr Opin Microbiol 2010; 13: 459-465.
17. Vaughan S. Assembly of the flagellum and its role in cell morphogenesis in Trypanosoma brucei. Curr Opin Microbiol 2010; 13: 453-458.
18. Hoare CA. The Trypanosomes of Mammals: A Zoological monograph. Oxford, Blackwell Scientific Publications, 1972.
19. Overath P & Engstler M. Endocytosis, membrane recycling and sorting of GPI-anchored proteins: Trypanosoma brucei as a model system. Mol Microbiol 2004; 53: 735-744.
20. Field MC & Carrington M. The trypanosome flagellar pocket. Nat Rev Microbiol 2009; 7: 775-786.
21. Matthews KR. The developmental cell biology of Trypanosoma brucei. J Cell Sci 2005; 118: 283-290.
22. Field MC, Allen CL, Dhir V, et al. New approaches to the microscopic imaging of Trypanosoma brucei. Microsc Microanal 2004; 10: 621-636.
23. Portman N & Gull K. Proteomics and the Trypanosoma brucei cytoskeleton: advances and opportunities. Parasitology 2012; 139: 1168-1177.
24. Matthews KR. Developments in the differentiation of Trypanosoma brucei. Parasitol Today 1999; 15: 76-80.
25. Rotureau B, Subota I & Bastin P. Molecular bases of cytoskeleton plasticity during the Trypanosoma brucei parasite cycle. Cell Microbiol 2011; 13: 705-716.
26. Sharma R, Peacock L, Gluenz E, Gull K, Gibson W & Carrington M. Asymmetric cell division as a route to reduction in cell length and change in cell morphology in trypanosomes. Protist 2008; 159: 137-151.
27. Vickerman K & Luckins AG. Localisation of variable antigens in the surface coat of Trypanosoma brucei using ferritin conjugated antibody. Nature 1969; 224: 1125-1126.
28. Vickerman K. Antigenic variation in trypanosomes. Nature 1978; 273: 613-617.
29. Rudenko G. African trypanosomes: the genome and adaptations for immune evasion. Essays Biochem 2011; 51: 47-62.
30. Horn D & McCulloch R. Molecular mechanisms underlying the control of antigenic variation in African trypanosomes. Curr Opin Microbiol 2010; 13: 700-705.
31. La Greca F & Magez S. Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist? Hum Vaccin 2011; 7: 1225-1233.
32. Price HP, Hodgkinson MR, Curwen RS, et al. The orthologue of Sjogren's syndrome nuclear autoantigen 1 (SSNA1) in Trypanosoma brucei is an immunogenic self-assembling molecule. PLoS One 2012; 7: e31842.
33. Wirtz E, Leal S, Ochatt C & Cross GA. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol 1999; 99: 89-101.
34. Price HP, Goulding D & Smith DF. ARL1 has an essential role in Trypanosoma brucei. Biochem Soc Trans 2005; 33: 643-645.
35. Price HP, Stark M & Smith DF. Trypanosoma brucei ARF1 plays a central role in endocytosis and golgi-lysosome trafficking. Mol Biol Cell 2007; 18: 864-873.
36. Farr H & Gull K. Cytokinesis in trypanosomes. Cytoskeleton (Hoboken) 2012; 69: 931-941.
37. Koyfman AY, Schmid MF, Gheiratmand L, et al. Structure of Trypanosoma brucei flagellum accounts for its bihelical motion. Proc Natl Acad Sci USA 2011; 108: 11105-11108.
38. Hoog JL, Bouchet-Marquis C, McIntosh JR, Hoenger A & Gull K. Cryo-electron tomography and 3-D analysis of the intact flagellum in Trypanosoma brucei. J Struct Biol 2012; 178: 189-198.
39. Gluenz E, Povelones ML, Englund PT & Gull K. The kinetoplast duplication cycle in Trypanosoma brucei is orchestrated by cytoskeleton-mediated cell morphogenesis. Mol Cell Biol 2011; 31: 1012-1021.
40. Lacomble S, Vaughan S, Gadelha C, et al. Three-dimensional cellular architecture of the flagellar pocket and associated cytoskeleton in trypanosomes revealed by electron microscope tomography. J Cell Sci 2009; 122: 1081-1090.
41. Hammarton TC, Monnerat S & Mottram JC. Cytokinesis in trypanosomatids. Curr Opin Microbiol 2007; 10: 520-527.
42. Hammarton TC, Clark J, Douglas F, Boshart M & Mottram JC. Stage-specific differences in cell cycle control in Trypanosoma brucei revealed by RNA interference of a mitotic cyclin. J Biol Chem 2003; 278: 22877-22886.
43. Price HP, Peltan A, Stark M & Smith DF. The small GTPase ARL2 is required for cytokinesis in Trypanosoma brucei. Mol Biochem Parasitol 2010; 173: 123-131.
44. Price HP, Hodgkinson MR, Wright MH, et al. A role for the vesicle-associated tubulin binding protein ARL6 (BBS3) in flagellum extension in Trypanosoma brucei. Biochim Biophys Acta 2012; 1823: 1178-1191.
45. Jin H, White SR, Shida T, et al. The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to cilia. Cell 2010; 141: 1208-1219.
46. Wang Y, Shyy JY & Chien S. Fluorescence proteins, live-cell imaging, and mechanobiology: seeing is believing. Annu Rev Biomed Eng 2008; 10: 1-38.
47. Buisson J, Chenouard N, Lagache T, Blisnick T, Olivo-Marin JC & Bastin P. Intraflagellar transport proteins cycle between the flagellum and its base. J Cell Sci 2013; 126: 327-338.
48. Price HP, MacLean L, Marrison J, O'Toole PJ & Smith DF. Validation of a new method for immobilising kinetoplastid parasites for live cell imaging. Mol Biochem Parasitol 2010; 169: 66-69.
49. Flinn HM, Rangarajan D & Smith DF. Expression of a hydrophilic surface protein in infective stages of Leishmania major. Mol Biochem Parasitol 1994; 65: 259-270.
50. Depledge DP, MacLean LM, Hodgkinson MR, et al. Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition. PLoS Negl Trop Dis 2010; 4: e829.
51. Sadlova J, Price HP, Smith BA, Votypka J, Volf P & Smith DF. The stage-regulated HASPB and SHERP proteins are essential for differentiation of the protozoan parasite Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol 2010; 12: 1765-1779.
52. Stager S, Smith DF & Kaye PM. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol 2000; 165: 7064-7071.
53. Maroof A, Brown N, Smith B, et al. Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis 2012; 205: 853-863.
54. Denny PW, Gokool S, Russell DG, Field MC & Smith DF. Acylation-dependent protein export in Leishmania. J Biol Chem 2000; 275: 11017-11025.
55. Maclean LM, O'Toole PJ, Stark M, et al. Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion. Cell Microbiol 2012; 14: 740-761.
56. Squirrell JM, Wokosin DL, White JG & Bavister BD. Long-term two-photon fluorescence imaging of mammalian embryos without compromising viability. Nat Biotechnol 1999; 17: 763-767.
57. Grab DJ, Nikolskaia O, Kim YV, et al. African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol 2004; 90: 970-979.
58. Grab DJ, Garcia-Garcia JC, Nikolskaia OV, et al. Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis 2009; 3: e479.
59. Abbott NJ, Ronnback L & Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53.
60. Beverley SM & Clayton CE. Transfection of Leishmania and Trypanosoma brucei by electroporation. Methods Mol Biol 1993; 21: 333-348.
61. Balmer O & Tostado C. New fluorescence markers to distinguish co-infecting Trypanosoma brucei strains in experimental multiple infections. Acta Trop 2006; 97: 94-101.
62. Quijada L, Guerra-Giraldez C, Drozdz M, et al. Expression of the human RNA-binding protein HuR in Trypanosoma brucei increases the abundance of mRNAs containing AU-rich regulatory elements. Nucleic Acids Res 2002; 30: 4414-4424.
63. Burkard G, Fragoso CM & Roditi I. Highly efficient stable transformation of bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol 2007; 153: 220-223.
64. Jennings FW & Gray GD. Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Contrib Microbiol Immunol 1983; 7: 147-154.
65. Peacock L, Ferris V, Bailey M & Gibson W. Intraclonal mating occurs during tsetse transmission of Trypanosoma brucei. Parasit Vectors 2009; 2: 43.
66. Peacock L, Ferris V, Bailey M & Gibson W. Dynamics of infection and competition between two strains of Trypanosoma brucei brucei in the tsetse fly observed using fluorescent markers. Kinetoplastid Biol Dis 2007; 6: 4.
67. Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L & Kristensson K. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 2004; 114: 689-694.
68. MacLean L, Odiit M, Macleod A, et al. Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-γ response. J Infect Dis 2007; 196: 1620-1628.
69. Rodgers J, McCabe C, Gettinby G, Bradley B, Condon B & Kennedy PG. Magnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis. Am J Trop Med Hyg 2011; 84: 344-350.
70. Mulenga C, Mhlanga JDM, Kristensson K & Robertson B. Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 2001; 27: 77-85.
71. Philip KA, Dascombe MJ, Fraser PA & Pentreath VW. Blood-brain-barrier damage in experimental African trypanosomiasis. Ann Trop Med Parasitol 1994; 88: 607-616.
72. Rodgers J, Jones A, Gibaud S, et al. Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. PLoS Negl Trop Dis 2011; 5: e1308.
73. Poltera AA, Hochmann A, Rudin W & Lambert PH. Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice-an immunological, histological and electron microscopic study. Clin Exp Immunol 1980; 40: 496-507.
74. Johnson RT, Green DE & Hirsch RL. Escape from immune surveillance within the central nervous system. In Miescher PA, Bolis L, Gorini S, Lambo TA, Nossal GJV, Torrigiani G (eds): Immunopathology of the Central and Peripheral Nervous System. Basel, Schwabe, 1979: 113-121.
75. Kennedy PG, Rodgers J, Jennings FW, Murray M, Leeman SE & Burke JM. A substance P antagonist, RP-67, 580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 1997; 94: 4167-4170.
76. Shaner NC, Lin MZ, McKeown MR, et al. Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Methods 2008; 5: 545-551.
77. Frevert U, Movila A, Nikolskaia OV, et al. Early invasion of brain parenchyma by African trypanosomes. PLoS One 2012; 7: e43913.
78. MacLean L, Reiber H, Kennedy PG & Sternberg JM. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. PLoS Negl Trop Dis 2012; 6: e1857.
79. Claes F, Vodnala SK, van Reet N, et al. Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness. PLoS Negl Trop Dis 2009; 3: e486.
80. Giroud C, Ottones F, Coustou V, et al. Murine models for Trypanosoma brucei gambiense disease progression: from silent to chronic infections and early brain tropism. PLoS Negl Trop Dis 2009; 3: e509.
81. Atouguia JM, Jennings FW & Murray M. Successful treatment of experimental murine Trypanosoma brucei infection with topical melarsoprol gel. Trans R Soc Trop Med Hyg 1995; 89: 531-533.
82. Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR & Brun R. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 2009; 53: 4185-4192.
83. Chung K, Wallace J, Kim SY, et al. Structural and molecular interrogation of intact biological systems. Nature 2013; 497: 332-337.